Reaction
Cervical Radiculopathy reporting signals
As of the last recalculation, Cervical Radiculopathy appears in 709 FAERS reports alongside 13 co-occurring drug terms. The strongest observed disproportionality signal is TIZANIDINE HYDROCHLORIDE (PRR 28.3).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Tizanidine Hydrochloride | 17 | 28.3 | 28.3 |
| Calcium, Magnesium, Potassium, And Sodium Oxybates | 7 | 24.1 | 24.1 |
| Terazosin Hydrochloride | 6 | 20.0 | 20.0 |
| Ado-Trastuzumab Emtansine | 4 | 14.0 | 14.0 |
| Linaclotide | 12 | 13.4 | 13.4 |
| Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Disoproxil Fumarate | 4 | 13.1 | 13.1 |
| Armodafinil | 9 | 12.7 | 12.7 |
| Diclofenac Potassium | 4 | 10.9 | 10.9 |
| Bictegravir Sodium, Emtricitabine, And Tenofovir Alafenamide Fumarate | 6 | 9.8 | 9.8 |
| Rimegepant Sulfate | 4 | 9.3 | 9.3 |
| Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Alafenamide | 3 | 8.8 | 8.8 |
| Tafamidis | 3 | 7.5 | 7.5 |
| Diroximel Fumarate | 3 | 7.4 | 7.4 |